Home > PJ (current issue) > Products | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 271 No 7260 p145
2 August 2003

This article
Reprint
Photocopy


Announcements


Announcements

May retail sales figures
The value of retail sales for May 2003, under the classification of pharmaceutical sales, was up one point at 129.

The classification of the retail sale of pharmaceutical, medical, cosmetic and toilet goods excludes National Health Service receipts. The figures are based on returns made by a number of large retail pharmacy chains, but exclude Boots The Chemists Ltd, which is classified under non-specialised retail stores. The figures are compiled by the Office for National Statistics.

Antepsin
Antepsin (sucralfate) tablets (previously Wyeth) will now be manufactured by E. Merck in packs of 100. Net price 1g 100 £8.75.

Fematrix and Femapak
Fematrix (estradiol) and the patches in Femapak (estradiol) are now presented in slimmer foil sachets. The constituents of the patch are unaltered.

Proctosedyl suppositories
Future supplies of Proctosedyl suppositories (cinchocaine hydrochloride and hydrocortisone) will require refrigeration at 2–8C. This will be printed on the new packs and will apply from batch 033331. Proctosedyl ointment should continue to be stored at ambient temperature.

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal